Singapore markets open in 5 hours 28 minutes

SymBio Pharmaceuticals Limited (4582.T)

Tokyo - Tokyo Delayed price. Currency in JPY
Add to watchlist
152.00-2.00 (-1.30%)
At close: 03:15PM JST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
4,642,760
5,589,708
10,008,338
8,252,582
2,987,051
-
Cost of revenue
1,003,902
1,178,694
2,408,434
2,452,471
2,120,198
-
Gross profit
3,638,857
4,411,013
7,599,904
5,800,110
866,853
-
Operating expenses
Selling general and administrative
-
-
-
-
-
5,166,366
Total operating expenses
5,308,474
5,222,681
5,636,278
4,784,109
5,373,073
-
Operating income or loss
-1,669,617
-811,668
1,963,626
1,016,001
-4,506,220
-
Income before tax
-2,022,657
-1,195,387
2,106,279
1,001,331
-4,086,416
-
Income tax expense
722,012
767,429
927,041
-1,030,871
3,800
-
Income from continuing operations
-2,744,669
-1,962,816
1,179,238
2,032,202
-4,090,216
-
Net income
-2,744,669
-1,962,817
1,179,238
2,032,203
-4,090,216
-
Net income available to common shareholders
-2,744,669
-1,962,817
1,179,238
2,032,203
-4,090,216
-
Basic EPS
-29.69
-49.19
30.20
53.04
-124.13
-
Diluted EPS
-29.69
-49.19
29.77
52.32
-124.13
-
Basic average shares
39,622
39,902
39,047
38,313
32,950
-
Diluted average shares
39,773
39,902
39,612
38,842
32,950
-